These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22365647)

  • 1. Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the SU.FOL.OM3 trial.
    Blacher J; Czernichow S; Paillard F; Ducimetiere P; Hercberg S; Galan P;
    Int J Cardiol; 2013 Jul; 167(2):508-13. PubMed ID: 22365647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S
    Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Galan P; Torrès M; Julia C; Hercberg S; Kesse-Guyot E
    Am J Clin Nutr; 2012 Jul; 96(1):208-14. PubMed ID: 22648722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH;
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):780-6. PubMed ID: 17699287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD.
    Szabo de Edelenyi F; Vergnaud AC; Ahluwalia N; Julia C; Hercberg S; Blacher J; Galan P
    Br J Nutr; 2012 Mar; 107(6):921-7. PubMed ID: 21801476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.
    Andreeva VA; Kesse-Guyot E; Barberger-Gateau P; Fezeu L; Hercberg S; Galan P
    Am J Clin Nutr; 2011 Jul; 94(1):278-86. PubMed ID: 21593490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics.
    Galan P; Briancon S; Blacher J; Czernichow S; Hercberg S
    Trials; 2008 Jun; 9():35. PubMed ID: 18544171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?
    Vesin C; Galan P; Gautier B; Czernichow S; Hercberg S; Blacher J
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):541-8. PubMed ID: 20216318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
    Galan P; Kesse-Guyot E; Czernichow S; Briancon S; Blacher J; Hercberg S;
    BMJ; 2010 Nov; 341():c6273. PubMed ID: 21115589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and interaction of low estimated GFR and B vitamin therapy on prognosis among ischemic stroke patients: the Vitamin Intervention for Stroke Prevention (VISP) trial.
    Lee M; Markovic D; Ovbiagele B
    Am J Kidney Dis; 2013 Jul; 62(1):52-7. PubMed ID: 23566636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial.
    Andreeva VA; Latarche C; Hercberg S; Briançon S; Galan P; Kesse-Guyot E
    PLoS One; 2014; 9(1):e84844. PubMed ID: 24465438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
    de Bree A; Mennen LI; Hercberg S; Galan P
    Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B vitamins and n-3 fatty acids for brain development and function: review of human studies.
    van de Rest O; van Hooijdonk LW; Doets E; Schiepers OJ; Eilander A; de Groot LC
    Ann Nutr Metab; 2012; 60(4):272-92. PubMed ID: 22678093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
    Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J;
    Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
    ; Bosch J; Gerstein HC; Dagenais GR; Díaz R; Dyal L; Jung H; Maggiono AP; Probstfield J; Ramachandran A; Riddle MC; Rydén LE; Yusuf S
    N Engl J Med; 2012 Jul; 367(4):309-18. PubMed ID: 22686415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
    Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
    Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.